AltruBio
Drug DiscoveryWebsite
AltruBio valuation and funding history | Last updated: May 21, 2024 | 1 funding rounds
Current Valuation
N/A
As of May 21, 2024
Total Funding Raised
$336.6M
Across 1 round
Last Round
Later Stage VC
$225.0M
Last Funding
May 2024
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| May 21, 2024 | Later Stage VC (Series B) | $225.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
AltruBio is currently valued at N/A as of May 21, 2024. The company has raised a total of $336.6M in funding across 1 funding round.
What is AltruBio Worth in 2026?
AltruBio is a leading private company in the Drug Discovery sector. Track AltruBio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How AltruBio Valuation is Determined
Private company valuations like AltruBio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.